139 related articles for article (PubMed ID: 12376206)
1. The prognostic significance of the tumour infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance.
Parker C; Milosevic M; Panzarella T; Banerjee D; Jewett M; Catton C; Tew-George B; Gospodarowicz M; Warde P
Eur J Cancer; 2002 Oct; 38(15):2014-9. PubMed ID: 12376206
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance.
Chung P; Daugaard G; Tyldesley S; Atenafu EG; Panzarella T; Kollmannsberger C; Warde P
Cancer Med; 2015 Jan; 4(1):155-60. PubMed ID: 25236854
[TBL] [Abstract][Full Text] [Related]
5. High endothelial venule-like vessels and lymphocyte recruitment in testicular seminoma.
Sakai Y; Hoshino H; Kitazawa R; Kobayashi M
Andrology; 2014 Mar; 2(2):282-9. PubMed ID: 24519996
[TBL] [Abstract][Full Text] [Related]
6. [Surveillance of stage I testicular seminoma: 20 years oncological results].
Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance-A systematic review.
Zengerling F; Kunath F; Jensen K; Ruf C; Schmidt S; Spek A
Urol Oncol; 2018 Oct; 36(10):448-458. PubMed ID: 28712790
[TBL] [Abstract][Full Text] [Related]
8. Pathological risk factors for higher clinical stage in testicular seminomas.
Trevino KE; Esmaeili-Shandiz A; Saeed O; Xu H; Ulbright TM; Idrees MT
Histopathology; 2018 Nov; 73(5):741-747. PubMed ID: 29858564
[TBL] [Abstract][Full Text] [Related]
9. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A
Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458
[TBL] [Abstract][Full Text] [Related]
10. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).
Tandstad T; Ståhl O; Dahl O; Haugnes HS; Håkansson U; Karlsdottir Å; Kjellman A; Langberg CW; Laurell A; Oldenburg J; Solberg A; Söderström K; Stierner U; Cavallin-Ståhl E; Wahlqvist R; Wall N; Cohn-Cedermark G;
Ann Oncol; 2016 Jul; 27(7):1299-304. PubMed ID: 27052649
[TBL] [Abstract][Full Text] [Related]
11. Stage II testicular seminoma: patterns of recurrence and outcome of treatment.
Chung PW; Gospodarowicz MK; Panzarella T; Jewett MA; Sturgeon JF; Tew-George B; Bayley AJ; Catton CN; Milosevic MF; Moore M; Warde PR
Eur Urol; 2004 Jun; 45(6):754-59; discussion 759-60. PubMed ID: 15149748
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Boormans JL; Sylvester R; Anson-Cartwright L; Glicksman RM; Hamilton RJ; Hahn E; Daugaard G; Lauritsen J; Wagner T; Avuzzi B; Nicolai N; Del Muro XG; Aparicio J; Stalder O; Rothermundt C; Fischer S; Laguna MP
Eur Urol Oncol; 2024 Jun; 7(3):537-543. PubMed ID: 37951820
[TBL] [Abstract][Full Text] [Related]
13. Surveillance in stage I testicular seminoma - risk of late relapse.
Chung P; Parker C; Panzarella T; Gospodarowicz MK; Jewett S; Milosevic MF; Catton CN; Bayley AJ; Tew-George B; Moore M; Sturgeon JF; Warde P
Can J Urol; 2002 Oct; 9(5):1637-40. PubMed ID: 12431325
[TBL] [Abstract][Full Text] [Related]
14. Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours.
Linder N; Taylor JC; Colling R; Pell R; Alveyn E; Joseph J; Protheroe A; Lundin M; Lundin J; Verrill C
J Clin Pathol; 2019 Feb; 72(2):157-164. PubMed ID: 30518631
[TBL] [Abstract][Full Text] [Related]
15. Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma.
Yakirevich E; Lefel O; Sova Y; Stein A; Cohen O; Izhak OB; Resnick MB
J Pathol; 2002 Jan; 196(1):67-75. PubMed ID: 11748644
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.
Tyldesley S; Voduc D; McKenzie M; Duncan G; Liu M; Wu D
Urology; 2006 Mar; 67(3):594-8. PubMed ID: 16527585
[TBL] [Abstract][Full Text] [Related]
17. Assessment of intravascular granulomas in testicular seminomas and their association with tumour relapse and dissemination.
Downes MR; Cheung CC; Pintilie M; Chung P; van der Kwast TH
J Clin Pathol; 2016 Jan; 69(1):47-52. PubMed ID: 26193899
[TBL] [Abstract][Full Text] [Related]
18. Correlation between primary tumor pathologic features and presence of clinical metastasis at diagnosis of testicular seminoma.
Valdevenito JP; Gallegos I; Fernández C; Acevedo C; Palma R
Urology; 2007 Oct; 70(4):777-80. PubMed ID: 17991554
[TBL] [Abstract][Full Text] [Related]
19. Surveillance following orchidectomy for stage I testicular seminoma.
Horwich A; Alsanjari N; A'Hern R; Nicholls J; Dearnaley DP; Fisher C
Br J Cancer; 1992 May; 65(5):775-8. PubMed ID: 1586607
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]